**7. HCV post-sustained virological response/antiviral therapy appraised by liver stiffness**

Due to their potency, ease of use, tolerability, and safety, DAA regiments are the recommended choice in subjects with compensated advanced chronic liver disease (cACLD). Their introduction resulted in increasing rates of SVR, reducing LS among these patients. Nonetheless, most of the studies concerning interferon-free treatments are retrospective, with small sample sizes, with short follow-up after SVR, and

